Zhejiang University

Introduction

Zhejiang University is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Zhejiang University (ZJU) is one of China's top national universities and a leading research institution in Asia. Founded in 1897, it has grown to become one of China's most prestigious universities with strong programs in medicine, life sciences, and neuroscience. The university is at the forefront of neurodegenerative disease research in China. [@zhejiang2024]

Overview

Introduction

Zhejiang University is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Zhejiang University (ZJU) is one of China's top national universities and a leading research institution in Asia. Founded in 1897, it has grown to become one of China's most prestigious universities with strong programs in medicine, life sciences, and neuroscience. The university is at the forefront of neurodegenerative disease research in China. [@zhejiang2024]

Overview

| Attribute | Details |
|-----------|---------|
| Location | Hangzhou, Zhejiang Province, China |
| Type | Public Research University |
| Founded | 1897 |
| Students | ~60,000 |
| Website | [zju.edu.cn](https://www.zju.edu.cn) |
| Medical School | Zhejiang University School of Medicine |
| Affiliated Hospitals | 7 affiliated hospitals |

History and Development

Founding and Early Years

Zhejiang University was founded in 1897 as Qiushi Academy (求是书院), making it one of China's oldest modern universities. The institution evolved through multiple transformations, including the merger of several specialized colleges in 1952 and subsequent expansions. The School of Medicine traces its roots to Zhejiang Provincial Medical School, established in 1912[@zhejiang2024].

Modern Era: International Research University

In the 1990s and 2000s, Zhejiang University underwent significant expansion, merging with the University of Hangzhou and other institutions to become one of China's largest and most comprehensive universities. The university's "World-Class University" initiative has propelled it into the top 100 globally, with particular strength in life sciences and medicine.

Neuroscience Research Programs

School of Medicine

Zhejiang University's School of Medicine conducts extensive research on neurodegenerative diseases through multiple institutes and centers[@zhejiang2024].

Institute of Neurology
The Institute focuses on:

• Molecular mechanisms of Alzheimer's and Parkinson's diseases
• Clinical research and drug trials
• Neuroimaging and biomarkers
• Genetic epidemiology in Chinese populations

• Neural circuit function and dysfunction
• Neurodevelopmental and neurodegenerative mechanisms
• Computational neuroscience
• Stem cell biology and regeneration

College of Biomedical Engineering and Instrumentation Science

Research areas include:

• Neural engineering and brain-machine interfaces
• Medical imaging for neurological disorders
• Biomedical devices for diagnosis and treatment
• Artificial intelligence in neuroimaging

Disease Focus

Research programs focus on:

• Alzheimer's Disease: Genetics, biomarkers, clinical trials, and traditional Chinese medicine approaches[@song2023][@liu2021]
• Parkinson's Disease: Epidemiology, treatment strategies, and genetic studies[@wang2022][@yu2023][@wu2022]
• Amyotrophic Lateral Sclerosis: Genetic studies, mechanisms, and stem cell therapy
• Stroke and Vascular Dementia: Vascular cognitive impairment and prevention[@tang2023]
• Frontotemporal Dementia: Tau pathology and clinical characterization

Notable Researchers

• Prof. Dr. Weihong Song: Vice President of ZJU, leading Alzheimer's disease researcher[@song2023]
• Prof. Dr. Lin Mei: Neuroscientist, neural development and disease
• Prof. Dr. Yun Wang: Parkinson's disease and movement disorders[@wang2022]
• Prof. Dr. Xin Chen: Neuroinflammation and microglia biology[@chen2023]

Research Facilities

• Zhejiang University School of Medicine affiliated hospitals
• National Clinical Research Center for Aging
• Brain bank and bioinformatics resources
• Clinical trial centers
• State-of-the-art neuroimaging facilities (MRI, PET)
• Stem cell research center
• Genomics and bioinformatics core

Key Research Programs

Alzheimer's Disease Program

The Alzheimer's disease research program at Zhejiang University encompasses:

Genetic Studies:

• Investigation of APP, PSEN1, PSEN2 mutations in Chinese families[@guo2022]
• APOE genotyping and risk assessment in Chinese populations[@lu2021]
• Genome-wide association studies (GWAS) in Chinese cohorts
• Identification of novel genetic risk factors unique to Asian populations

• Blood-based biomarker discovery for early diagnosis[@gong2022]
• CSF biomarker validation studies
• Neuroimaging biomarkers for disease progression[@yang2022]
• Development of culturally appropriate cognitive assessments

• Participation in international multi-center trials for anti-amyloid therapies
• Testing of novel tau aggregation inhibitors
• Immunotherapy trials for Alzheimer's disease[@feng2020]

Parkinson's Disease Program

The Parkinson's disease research program focuses on:

Genetic Studies:

• LRRK2 mutation frequency and phenotype in Chinese PD patients[@wu2022]
• GBA mutations in Chinese populations[@yu2023]
• Investigation of PARK genes in Chinese families
• PINK1 and DJ-1 studies in early-onset PD

• Deep brain stimulation outcomes in Chinese patients[@lin2020]
• Movement disorders clinic with comprehensive care
• Non-motor symptom characterization
• Sleep disorders and cognitive dysfunction in PD[@he2021]

• Stem cell therapy approaches[@zhao2021]
• Gene therapy research
• Traditional Chinese medicine interventions[@xu2019]

Neuroinflammation Research

Zhejiang University has established a strong program in neuroinflammation:

• Microglial activation studies in Alzheimer's disease[@chen2023]
• Inflammatory cytokine profiling
• Gut microbiome and brain axis in neurodegeneration[@huang2023]
• Anti-inflammatory therapeutic approaches

International Collaborations

• Partnerships with major US universities (Harvard, MIT, Stanford)
• Collaboration with European research institutions
• Asian Neuroscience Network
• Cross-Strait neuroscience collaboration
• Joint research programs with Japanese and Korean institutions

Traditional Chinese Medicine and Neurodegeneration

Zhejiang University has established a unique program investigating traditional Chinese medicine (TCM) approaches to neurodegenerative diseases[@xu2019].

Research Areas

Herbal Medicine Studies:

• Investigation of compounds like baicalein, curcumin, and ginsenosides
• Mechanisms of neuroprotection
• Standardization and quality control of herbal preparations
• Clinical trials of TCM formulations

• Acupuncture for cognitive improvement in MCI and AD
• Mechanism studies on neurotransmitter modulation
• Clinical trials on PD motor symptoms
• Integration with Western medical approaches

Key TCM Compounds Under Investigation

| Compound | Source | Potential Application |
|----------|--------|----------------------|
| Baicalein | Scutellaria baicalensis | Anti-inflammatory, neuroprotective |
| Curcumin | turmeric | Antioxidant, anti-amyloid |
| Ginsenosides | Panax ginseng | Cognitive enhancement |
| Huperzine A | Huperzia serrata | Acetylcholinesterase inhibitor |

Key Laboratories

Zhejiang University hosts several key research laboratories:

• State Key Laboratory of Cognitive Neuroscience and Learning
• Zhejiang Provincial Key Laboratory of Neurology
• National Engineering Research Center for Biomedical Imaging
• Center for Brain Disorders and Cognitive impairment

Laboratory Focus Areas

Each laboratory maintains specialized research programs:

State Key Laboratory of Cognitive Neuroscience

• Neural basis of learning and memory
• Developmental neuroscience
• Cognitive aging mechanisms

• Clinical translation of basic discoveries
• Biomarker development
• Therapeutic intervention studies

Recent Research Developments

Zhejiang University has emerged as a leading center for neurodegeneration research in China:

• Alzheimer's Research: The Song Lab discovered novel mechanisms of [Aβ](/proteins/amyloid-beta) toxicity and developed potential therapeutic compounds.
• Parkinson's Studies: Clinical trials for deep brain stimulation and pharmacological interventions.
• Stem Cell Research: iPSC-derived [neurons](/entities/neurons) for disease modeling and drug screening.

Drug Discovery and Traditional Medicine

A distinctive aspect of Zhejiang's research is the integration of traditional Chinese medicine:

Natural Product Screening

• Curcumin and its derivatives for neuroprotection
• Baicalein from Scutellaria baicalensis for anti-inflammatory effects
• Ginsenosides for cognitive enhancement
• Multi-target approach using herbal formulations

• Mitochondrial protection pathways
• Anti-oxidant mechanisms
• Neuroinflammation modulation
• Autophagy induction

Clinical Research Infrastructure

The university maintains comprehensive clinical research capabilities:

Affiliated Hospitals

• First Affiliated Hospital of Zhejiang University
• Sir Run Run Shaw Hospital
• Zhejiang Provincial People's Hospital

• Phase 1-4 clinical trial experience
• Specialized memory disorders clinics
• Movement disorders center
• Clinical pharmacology unit

Training Programs

The university provides excellent research training:

• MD/PhD Program: Combined clinical and research training in neurology
• Neuroscience Graduate Program: World-class training in cellular and systems neuroscience
• International Collaborations: Students can rotate at partner institutions worldwide
• Postdoctoral Training: Extensive postdoctoral positions in neurodegeneration research
• Clinical Fellowships: Sub-specialty training in cognitive neurology and movement disorders

Clinical Trials Infrastructure

Zhejiang University participates in numerous clinical trials:

| Condition | Focus | Phase | Status |
|-----------|-------|-------|--------|
| Alzheimer's disease | Anti-amyloid antibody | Phase 3 | Recruiting |
| Alzheimer's disease | Tau aggregation inhibitor | Phase 2 | Ongoing |
| Parkinson's disease | Gene therapy | Phase 1/2 | Enrolling |
| Alzheimer's disease | Traditional Chinese medicine | Phase 2 | Active |
| Vascular dementia | Prevention trial | Phase 3 | Recruiting |

Summary and Global Impact

Zhejiang University has emerged as a leading center for neurodegeneration research in China, contributing significantly to understanding neurodegenerative diseases in Asian populations. The institution's unique strengths include:

The university's commitment to combining cutting-edge neuroscience research with its unique cultural heritage positions it as a critical contributor to the global effort against neurodegenerative diseases.

References

• [Zhejiang University School of Medicine](https://www.cmm.zju.edu.cn)](/institutions/zhejiang-university)
• [State Key Laboratory](https://klcnl.zju.edu.cn)

Recent Discoveries and Research Directions

Zhejiang University has emerged as a leading center for neurodegenerative disease research in China. Key research directions include:

Alzheimer's Disease Research

• Traditional medicine: Investigation of herbal compounds for neuroprotection
• Stem cell therapy: Development of iPSC-based approaches for disease modeling
• Neuroimaging: Advanced MRI techniques for early detection

Parkinson's Disease Research

• Chinese herbal medicine: Studies on compounds like baicalein and curcumin
• Acupuncture research: Clinical trials on PD symptom management
• Environmental factors: Investigation of pesticide exposure and PD risk

Collaborative Research Centers

The university hosts several key research centers:

• Institute of Neuroscience: Focused on basic mechanisms of neurodegeneration
• Center for Brain Science: Interdisciplinary approach to brain disorders
• International Institute for Brain-Inspired Intelligence: AI applications in neuroscience
• Zhejiang Provincial Center for Neurological Disease: Regional healthcare coordination

Cross-Disciplinary Programs

Zhejiang University emphasizes interdisciplinary collaboration:

Neuroscience + Engineering

• Brain-computer interfaces
• Neural prosthetics
• Medical imaging device development

• AI-assisted diagnosis
• Big data analytics for neuroimaging
• Machine learning for biomarker discovery

• Pharmacology of herbal compounds
• Clinical trials of traditional formulations
• Mechanism of acupuncture effects

Training Programs

Zhejiang University offers comprehensive training in neurodegenerative disease research:

• Medical Degree Programs: Neurology and psychiatry residency training
• Graduate Research Programs: PhD in Neuroscience, Biochemistry, Pharmacology
• International Exchange: Partnerships with universities in US, Europe, and Japan
• Clinical Research Training: Programs in experimental neurology and therapeutics

Funding and Research Investment

Zhejiang University's neurodegeneration research is supported by major funding sources:

National Funding Programs

• National Natural Science Foundation of China (NSFC): Major grants for basic and clinical research
• National Key R&D Program: Government-funded therapeutic development
• Chinese Academy of Sciences: Strategic priority programs
• Provincial funding: Zhejiang Province science and technology projects

Industry Partnerships

• Collaboration with Chinese pharmaceutical companies
• Contract research services
• Joint drug development programs
• Venture capital for spin-off companies

Research Investment Summary

| Funding Source | Annual Investment (RMB) | Focus Area |
|----------------|------------------------|------------|
| NSFC | ¥50+ million | Basic mechanisms |
| Key R&D Program | ¥100+ million | Therapeutic development |
| Industry partnerships | ¥30+ million | Drug discovery |
| Provincial funding | ¥20+ million | Clinical research |

International Collaboration Strategy

Zhejiang University has developed strategic international partnerships:

Partner Institutions

• Harvard Medical School (USA)
• University College London (UK)
• Max Planck Society (Germany)
• RIKEN Brain Science Institute (Japan)
• Karolinska Institute (Sweden)

Collaboration Programs

Joint Research

• Co-authored publications with international partners
• Shared laboratory protocols and methods
• Collaborative clinical trials
• Data sharing agreements

• Semester abroad programs
• Summer research internships
• Visiting professor appointments
• Joint doctoral supervision

• Annual Zhejiang Neuroscience Symposium
• Joint workshops with partner institutions
• Conference travel support for graduate students

Summary and Regional Leadership

Zhejiang University has established itself as a leading center for neurodegenerative disease research in China and Asia. Its unique strengths include:

The university's position as one of China's "C9 League" institutions ensures sustained investment in neuroscience research.

References